SLDB Solid Biosciences Inc.

Fundamentals / CIK 0001707502 / USD

Solid Biosciences Inc. reported $389.9M in total assets and a net loss of $215.3M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open SLDB in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$31.83M$15.92M$0-$164.2MFY 2016 Revenue: $0FY 2016 Net Income: -$21.54M2016FY 2017 Revenue: $0FY 2017 Net Income: -$52.12M2017FY 2018 Revenue: $0FY 2018 Net Income: -$74.80M2018FY 2019 Revenue: $0FY 2019 Net Income: -$117.2M2019FY 2020 Revenue: $0FY 2020 Net Income: -$88.29M2020FY 2021 Revenue: $13.62MFY 2021 Net Income: -$72.19M2021FY 2022 Revenue: $8.09MFY 2022 Net Income: -$85.98M2022FY 2023 Net Income: -$96.02M2023FY 2024 Net Income: -$124.7M2024FY 2025 Net Income: -$174.3M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- -- -- $8.09M $13.62M $0 $0 $0 $0 $0
Research & Development $140.3M $96.43M $76.56M $78.42M $58.74M $64.88M $94.74M $57.97M $39.91M $20.12M
Total Operating Expenses $179.2M $129.7M $104.3M $114.5M $85.87M $88.41M $119.3M $75.69M $54.86M $25.58M
Operating Income -$179.2M -$129.7M -$104.3M -$106.5M -$72.25M -$88.41M -$119.3M -$75.69M -$54.86M -$25.58M
EBITDA -$177.6M -$127.3M -$101.7M -$104.0M -$69.29M -$84.48M -$116.5M -$74.12M -$54.41M -$25.52M
Interest Income $9.90M $9.47M $7.58M $2.62M $64K $115K $1.58M $619K $219K $369K
Interest Expense -$203K $340K $440K -- -- -- -- -- -- --
Income Before Tax -$174.2M -$124.6M -- -- -- -- -- -- -- --
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0 -- --
Net Income -$174.3M -$124.7M -$96.02M -$85.98M -$72.19M -$88.29M -$117.2M -$74.80M -$52.12M -$21.54M
Basic EPS -$1.99 -$3.06 -$4.83 -$10.10 -$10.14 -$25,500.00 -$2,910.00 -$2,250.00 -$2,880.00 -$10,140.00
Diluted EPS -$1.99 -$3.06 -$4.83 -$10.10 -$10.14 -$25,500.00 -$2,910.00 -$2,250.00 -$2,880.00 -$10,140.00
Basic Shares Outstanding 87.5M 40.8M 19.9M 8.5M 7.1M 3.5K 40.3K 33.3K 13.6K 1.7K
Diluted Shares Outstanding 87.5M 40.8M 19.9M 8.5M 7.1M 3.5K 40.3K 33.3K 13.6K 1.7K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $43.59M $44.27M $46.14M $38.13M $38.86M $32.41M $30.91M $30.77M
Total Operating Expenses $57.66M $57.38M $57.31M $49.40M $48.06M $41.69M $40.05M $39.90M
Operating Income -$57.66M -$57.38M -$57.31M -$49.40M -$48.06M -$41.69M -$40.05M -$39.90M
EBITDA -$57.24M -$56.99M -$56.91M -$48.94M -$47.68M -$41.31M -$39.65M -$39.41M
Interest Income $3.34M $3.22M $2.06M $2.05M $2.59M $2.97M $2.30M $1.93M
Interest Expense -- -- -- $5.0K -$336K $60K $68K $75K
Net Income -$53.95M -$54.80M -$56.74M -$49.79M -$45.78M -$39.48M -$39.28M -$42.60M
Basic EPS -$0.36 -$0.38 -$0.52 -- -$0.48 -$0.42 -$0.59 --
Diluted EPS -$0.36 -$0.38 -$0.52 -- -$0.48 -$0.42 -$0.59 --
Basic Shares Outstanding 151.0M 143.7M 109.8M -- 94.4M 94.1M 66.3M --
Diluted Shares Outstanding 151.0M 143.7M 109.8M -- 94.4M 94.1M 66.3M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $59.90M $80.23M $74.02M $155.4M $119.1M $154.7M $76.04M $86.37M $52.08M
Short-Term Investments $128.0M $68.69M $49.62M $58.34M $88.64M -- $7.48M $36.10M $17.01M
Cash & Short-Term Investments $187.9M $148.9M $123.6M $213.7M $207.8M $154.7M $83.52M $122.5M $69.09M
Total Current Assets $205.5M $157.3M $129.7M $219.6M $222.6M $158.9M $86.30M $128.6M $70.66M
Property, Plant & Equipment, Net $4.17M $4.75M $6.62M $9.66M $6.46M $8.15M $11.64M $10.42M $2.43M
Other Non-Current Assets $223K $366K $209K $175K $94K $209K $209K $209K --
Total Non-Current Assets $27.08M $31.36M $35.20M $40.61M $9.77M $12.27M $17.17M $10.96M $5.54M
Total Assets $232.5M $188.7M $164.9M $260.3M $232.4M $171.2M $103.5M $139.6M $76.19M
Accounts Payable $3.22M $4.24M $2.03M $3.24M $4.46M $3.27M $7.12M $3.69M $5.07M
Deferred Revenue (Current) -- -- -- -- $8.08M $10.36M -- -- --
Other Current Liabilities -- -- $24K $14K $35K -- $52K $382K $233K
Total Current Liabilities $33.47M $30.26M $14.52M $22.51M $23.60M $24.48M $18.28M $12.48M $11.27M
Deferred Revenue (Non-Current) -- -- -- -- -- $10.36M -- -- --
Other Non-Current Liabilities -- -- -- $96K -- $1.30M -- $1.07M --
Total Non-Current Liabilities $19.06M $21.16M $23.94M $26.08M $568K $14.60M $5.15M $1.93M $0
Total Liabilities $52.53M $51.42M $38.46M $48.59M $24.17M $39.08M $23.42M $14.41M $11.27M
Total Debt (incl. Leases) $21.16M $24.18M $26.27M $28.55M $2.06M $5.15M $7.07M $1.03M --
Common Stock $79K $40K $20K $20K $7.0K $87K $48K $35K --
Retained Earnings -$957.8M -$783.5M -$658.8M -$562.7M -$476.8M -$404.6M -$316.3M -$199.1M -$124.3M
Accumulated Other Comp. Income $52K $47K $15K -$68K -$45K $0 $1.0K -$5.0K -$13K
Total Stockholders' Equity $180.0M $137.2M $126.5M $211.7M $208.2M $132.1M $80.05M $125.2M -$59.26M
Total Equity $180.0M $137.2M $126.5M $211.7M $208.2M $132.1M $80.05M $125.2M -$59.26M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $126.0M $159.4M $297.1M $59.90M $61.36M $138.9M $210.6M $80.23M
Short-Term Investments $223.0M $218.3M $83.58M $128.0M $174.8M $129.2M $96.29M $68.69M
Cash & Short-Term Investments $348.9M $377.7M $380.7M $187.9M $236.1M $268.1M $306.9M $148.9M
Total Current Assets $365.2M $395.1M $396.8M $205.5M $244.9M $278.6M $313.4M $157.3M
Property, Plant & Equipment, Net $3.73M $3.96M $3.91M $4.17M $4.36M $4.32M $4.48M $4.75M
Other Non-Current Assets $248K $138K $183K $223K $247K $278K $319K $366K
Total Non-Current Assets $24.71M $25.47M $26.11M $27.08M $29.06M $29.65M $30.50M $31.36M
Total Assets $389.9M $420.6M $422.9M $232.5M $273.9M $308.3M $343.9M $188.7M
Accounts Payable $3.23M $4.36M $5.56M $3.22M $8.43M $4.70M $6.44M $4.24M
Total Current Liabilities $30.45M $28.58M $30.28M $33.47M $36.34M $29.85M $28.78M $30.26M
Total Non-Current Liabilities $17.34M $17.92M $18.48M $19.06M $19.62M $20.16M $20.66M $21.16M
Total Liabilities $47.79M $46.51M $48.76M $52.53M $55.97M $50.00M $49.44M $51.42M
Total Debt (incl. Leases) $19.62M $20.16M $20.67M $21.16M $21.94M $23.05M $23.63M $24.18M
Common Stock $112K $105K $98K $79K $78K $78K $77K $40K
Retained Earnings -$1.12B -$1.07B -$1.01B -$957.8M -$908.0M -$862.2M -$822.7M -$783.5M
Accumulated Other Comp. Income -$161K -$113K -$13K $52K $48K -$38K $2.0K $47K
Total Stockholders' Equity $342.1M $374.1M $374.1M $180.0M $217.9M $258.3M $294.5M $137.2M
Total Equity $342.1M $374.1M $374.1M $180.0M $217.9M $258.3M $294.5M $137.2M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$174.3M -$124.7M -$96.02M -$85.98M -$72.19M -$88.29M -$117.2M -$74.80M -$53.18M -$23.77M
Depreciation & Amortization $1.64M $2.46M $2.58M $2.41M $2.96M $3.92M $2.82M $1.57M $448K $56K
Stock-Based Compensation $16.91M $10.52M $7.62M $7.54M $13.37M $11.63M $14.21M $5.96M $5.33M $1.47M
Change in Payables -$1.09M $2.21M -$764K -$5.25M $1.21M -$3.43M $3.78M -$1.61M $1.58M $2.21M
Operating Cash Flow -$156.3M -$100.0M -$94.18M -$97.98M -$77.76M -$56.60M -$92.71M -$70.20M -$43.22M -$20.12M
Capital Expenditure -$1.15M -$654K -$1.51M -$3.02M -$1.28M -$899K -$4.39M -$7.78M -$2.28M -$392K
Free Cash Flow -$157.4M -$100.7M -$95.69M -$101.0M -$79.05M -$57.50M -$97.10M -$77.97M -$45.50M -$20.51M
Purchases of Investments -$235.9M -$204.3M -$117.4M -$182.8M -$141.2M -$401K -$31.50M -$44.32M -$18.90M -$25.70M
Investing Cash Flow -$58.45M -$16.09M $9.69M $59.16M -$91.09M $6.60M $24.52M -$26.76M $10.45M -$4.05M
Common Stock Issued -- -- $2.97M $72.55M $134.9M $113.2M $49.33M -- -- --
Financing Cash Flow $194.4M $122.4M $3.12M $74.83M $135.0M $128.7M $57.88M $131.5M $77.08M $3.42M
Net Change in Cash -$20.30M $6.34M -$81.37M $36.01M -$33.87M $78.70M -$10.32M $34.55M $44.30M -$20.75M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$53.95M -$54.80M -$56.74M -$49.79M -$45.78M -$39.48M -$39.28M -$42.60M
Depreciation & Amortization $416K $391K $395K $467K $376K $386K $407K $488K
Stock-Based Compensation $6.15M $5.62M $5.15M $6.50M $3.93M $3.15M $3.34M $3.82M
Change in Payables -$1.13M -$1.18M $2.32M -$5.26M $3.70M $6.0K $461K $815K
Operating Cash Flow -$45.55M -$52.59M -$47.23M -$53.55M -$33.47M -$37.41M -$31.85M -$29.64M
Capital Expenditure -$498K -$150K -$165K -$565K -$85K -$377K -$126K -$204K
Free Cash Flow -$46.04M -$52.74M -$47.40M -$54.12M -$33.56M -$37.79M -$31.98M -$29.85M
Purchases of Investments -$92.66M -$151.9M -$83.46M -$23.92M -$83.19M -$63.44M -$65.34M -$15.33M
Investing Cash Flow -$3.76M -$133.6M $44.76M $47.01M -$45.27M -$32.73M -$27.46M $38.57M
Financing Cash Flow $15.88M $48.47M $239.0M $5.14M $1.18M -$1.60M $189.7M $6.94M
Net Change in Cash -$33.42M -$137.7M $236.6M -$1.40M -$77.57M -$71.75M $130.4M $15.86M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -- -- -- -1315.2% -530.5% -- -- -- -- --
Net Profit Margin -- -- -- -1062.3% -530.0% -- -- -- -- --
Return on Equity (ROE) -96.8% -90.9% -75.9% -40.6% -34.7% -66.8% -146.4% -59.8% -- --
Return on Assets (ROA) -75.0% -66.1% -58.2% -33.0% -31.1% -51.6% -113.3% -53.6% -68.4% --
Current Ratio 6.14x 5.20x 8.94x 9.76x 9.43x 6.49x 4.72x 10.31x 6.27x --
Quick Ratio 5.61x 4.92x 8.52x 9.50x 8.80x 6.32x 4.57x 9.81x 6.13x --
Debt to Equity 0.12x 0.18x 0.21x 0.13x 0.01x 0.04x 0.09x 0.01x -- --
Revenue Growth (YoY) -- -- -- -40.6% -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -62.9% -55.4% -51.3% -96.8% -76.7% -59.7% -47.4% -90.9%
Return on Assets (ROA) -55.2% -49.2% -45.3% -75.0% -61.0% -50.0% -40.6% -66.1%
Current Ratio 11.99x 13.82x 13.10x 6.14x 6.74x 9.34x 10.89x 5.20x
Quick Ratio 11.46x 13.21x 12.57x 5.61x 6.50x 8.98x 10.66x 4.92x
Debt to Equity 0.06x 0.05x 0.06x 0.12x 0.10x 0.09x 0.08x 0.18x
Source: SEC EDGAR CompanyFacts (CIK 0001707502) · from December 31, 2016 Data through September 30, 2026 · synced Nov 20, 2026, 05:32 UTC · Open in terminal